微信公众号

官网二维码

中国癌症防治杂志 ›› 2022, Vol. 14 ›› Issue (4): 393-399.doi: 10.3969/j.issn.1674-5671.2022.04.06

• 临床研究 • 上一篇    下一篇

腋窝临床淋巴结阳性超声特征与乳腺癌淋巴结转移负荷及预后的相关性研究

  

  1. 上海交通大学医学院附属瑞金医院普外科,乳腺疾病诊治中心
  • 出版日期:2022-08-25 发布日期:2022-09-08
  • 通讯作者: 沈坤炜 E-mail:kwshen@medmail.com.cn; 陈小松 E-mail:chenxiaosong0156@hotmail.com
  • 基金资助:
    国家自然科学基金项目(81772797);上海教育委员会高峰高原计划-研究型医师(20172007)

Correlation of clinical axillary lymph node⁃positive ultrasound features with lymph node metastasis burden and prognosis in breast cancer

  • Online:2022-08-25 Published:2022-09-08

摘要: 目的 分析腋窝临床淋巴结阳性乳腺癌患者的腋窝淋巴结超声特征,探索超声特征与腋窝淋巴结转移负荷及患者预后的相关性。方法 研究入组2009年1月至2020年12月于本中心接受腋窝淋巴结清扫术的临床淋巴结阳性乳腺癌患者,分析可预测腋窝淋巴结转移负荷的临床病理指标和超声指标。利用多因素Cox回归分析影响患者预后的超声指标。结果 共纳入1 055例乳腺癌患者,其中低淋巴结负荷(1~2枚淋巴结转移)398例(37.7%),高淋巴结负荷(≥3枚淋巴结转移)657例(62.3%)。多因素分析显示,患者年龄≥55岁(OR=1.56,95%CI:1.20~2.02,P=0.001),超声肿瘤大小<20.0 mm(OR=1.54,95%CI:1.14~2.09,P=0.005)、超声淋巴结长径<20.0 mm(OR=2.03,95%CI:1.48~2.79,P<0.001)、超声淋巴结短径<8.6 mm(OR=1.41,95%CI:1.06~1.89,P=0.019)和超声可疑淋巴枚数1~2枚(OR=2.74,95%CI:1.63~4.61,P<0.001)与低淋巴结负荷独立相关。孕激素受体和淋巴结长径是DFS(HR=2.06,95%CI:1.21~3.50,P=0.008;HR=1.66,95%CI:1.15~2.40,P=0.007)和OS(HR=4.53,95%CI:2.18~9.59,P<0.001;HR=3.49,95%CI:1.96~6.20,P<0.001)的独立预测因素。结论 超声特征有助于预测腋窝临床淋巴结阳性乳腺癌患者的淋巴结转移负荷及预后,指导后续个体化治疗。

关键词: 乳腺癌, 临床淋巴结阳性, 淋巴结转移负荷, 超声特征, 前哨淋巴结, 预后

Abstract: Objective To analyze the ultrasound features of patients with clinical axillary lymph node-positive breast cancer, and to explore the correlation of ultrasound features with lymph node metastasis burden and prognosis. Methods The patients with clinical node-positive disease who underwent axillary lymph node dissection in our center between January 2009 and December 2020 were included. The clinicopathological and ultrasonographic indicators that could predict the lymph node metastasis burden were retrospectively analyzed. Multivariable Cox regression was used to explore the ultrasonographic predictors affecting the prognosis. Results A total of 1,055 breast cancer patients were included in the study, including 398 patients (37.7%) with low nodal burden (1-2 lymph node metastases) and 657 patients (62.3%) with high nodal burden (≥3 lymph node metastases). Multivariable analysis indicated that the age of patients ≥55 years old (OR=1.56, 95%CI: 1.20-2.02, P=0.001), the ultrasound tumor size <20.0 mm (OR=1.54, 95%CI: 1.14-2.09, P=0.005), long diameter of lymph node <20.0 mm (OR=2.03, 95%CI: 1.48-2.79, P<0.001), short diameter of lymph node <8.6 mm (OR=1.41, 95%CI: 1.06-1.89, P=0.019) and 1-2 suspicious lymph nodes (OR=2.74, 95%CI: 1.63-4.61, P<0.001) were independently associated with low nodal burden. The progesteron receptor status and the long diameter of lymph node were independent predictors of disease-free survival (HR=2.06, 95%CI: 1.21-3.50, P=0.008; HR=1.66,95%CI: 1.15-2.40, P=0.007) and overall survival (HR=4.53, 95%CI: 2.18~9.59, P<0.001; HR=3.49,95%CI:1.96-6.20, P<0.001). Conclusions Ultrasound features can help predict lymph nodal metastasis burden and prognosis of patients with clinical axillary node?positive breast cancer, and guide subsequent individualized treatment.

Key words: Breast cancer, Clinical lymph node-positive, Lymph node metastasis burden, Ultrasound features, Sentinel lymph node biopsy, Prognosis

中图分类号: 

  • R737.9